Formulation and Evaluation of Domperidone Nanoemulsions for Oral Rout

Formulation and Evaluation of Domperidone Nanoemulsions for Oral Rout

Show other versions (2)

The aim of the present study is to formulate, evaluate and characterize the nanoemulsion of Domperidone a poorly water-soluble anti-emetic drug. Domperidone powder is white or almost white powder, photosensitive, practically insoluble in water, slightly soluble in ethanol and in methan...

Full description

Bibliographic Details
Main Authors:	Mohanad N. Taher, Ahmed A. Hussein
Format:	Article
Language:	English
Published:	College of Pharmacy University of Baghdad 2017-01-01
Series:	Iraqi Journal of Pharmaceutical Sciences
Subjects:	:Nanoemulsion, Domperidone
Online Access:	https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/47

Similar Items

Formulation and Evaluation of Domperidone Nanoemulsions for Oral Rout
by: Mohanad N. Taher, et al.
Published: (2017-04-01)

Formulation and Evaluation of Domperidone Nanoemulsions for Oral Rout
by: Mohanad N. Taher, et al.
Published: (2017-04-01)

FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF DOMPERIDONE MALEATE
by: Yuwaraj Dilipsingh Dixit, et al.
Published: (2013-01-01)

Formulation development and evaluation of mouth dissolving film of domperidone
by: Pratikkumar Joshi, et al.
Published: (2012-01-01)

Short review on domperidone tablet
by: Shaveta Sharma, et al.
Published: (2017-01-01)

Benefits of domperidone in ambulatory acute diarrhea with severe vomiting
by: Irene A. O., et al.
Published: (2007-10-01)

Domperidone and maternal milk volume in mothers of premature newborns
by: Tengku Ellya Fazilla, et al.
Published: (2017-02-01)

In vitro Transdermal Transport of Domperidone by Compartmental Modeling Approach
by: Sekar Ayu Pawestri, et al.
Published: (2021-01-01)

Use of domperidone in canine visceral leishmaniasis: gaps in veterinary knowledge and epidemiological implications
by: Bruno L Travi, et al.
Published: (2018-10-01)

Evaluation of the Additive Effect of Domperidone on Patients with Refractory Gastroesophageal Reflux Disease Symptoms; A Randomized Double Blind Clinical Trial
by: Tarang Taghvaei, et al.
Published: (2019-01-01)

Domperidone: Pharmacists Stimulating Clinical Change for Lactation Consultants
by: Katherine Chinnery, et al.
Published: (2024-01-01)

Domperidone‐induced pityriasis rosea‐like drug eruption
by: Sarra Saad, et al.
Published: (2022-04-01)

UTILIZATION OF BROMINATION REACTION FOR THE SPECTROPHOTOMETRIC ASSAY OF DOMPERIDONE IN PHARMACEUTICALS
by: O. ZENITA DEVI, et al.
Published: (2011-03-01)

Effects of Domperidone on QT Interval in Children with Gastroesophageal Reflux Disease
by: Thitima Ngoenmak, et al.
Published: (2016-02-01)

Is the combination of domperidone and metoclopramide increasing the risk of developing serotonin syndrome?: a case report
by: Abdullah Nasser Aldosari, et al.
Published: (2024-04-01)

Efficacy comparison between oral erythromycin versus domperidone for the treatment of feeding intolerance in preterm neonatesWhat's known on this subjectWhat this study adds
by: Pattarapan Sukwuttichai, et al.
Published: (2021-09-01)

Impact of preoperative oral domperidone on gastric residual volume after clear fluid ingestion in patients scheduled for elective surgery: a randomized controlled trial
by: Sherif S. Sultan, et al.
Published: (2024-12-01)

Efficacy and Safety of Domperidone in Combination with Proton Pump Inhibitors in Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
by: Nur Fathurah Zamani, et al.
Published: (2022-09-01)

Formulation and Characterization of Felodipine as an Oral Nanoemulsions
by: Sumaya B. Hamed, et al.
Published: (2021-06-01)

Formulation and Characterization of Isradipine as Oral Nanoemulsion
by: Noor A. sadoon, et al.
Published: (2020-06-01)

Ethosomal gel for rectal transmucosal delivery of domperidone: design of experiment, in vitro, and in vivo evaluation
by: Wedad Sakran, et al.
Published: (2022-12-01)

Box-Behnken Assisted Validation and Optimization of an RP-HPLC Method for Simultaneous Determination of Domperidone and Lansoprazole
by: Mohd Afzal, et al.
Published: (2021-01-01)

Effects of ondansetron alone and in combination with domperidone in the prevention of chemotherapy-induced nausea and vomiting in breast cancer patients
by: Kaberi Das Gupta, et al.
Published: (2007-06-01)

Preparation and characterization of domperidone nanoparticles for dissolution improvement
by: Mohammed Sabar Al-lami, et al.
Published: (2018-06-01)

Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma
by: Qiang Yuan, et al.
Published: (2024-03-01)

Pilot Study on QTc Interval in Dogs Treated with Domperidone
by: Giulia Donato, et al.
Published: (2024-01-01)

Formulation and Investigation of Lacidipine as a Nanoemulsions
by: Rajaa A. Dahash, et al.
Published: (2020-06-01)

Effect of domperidone (leisguard®) on antibody titers, inflammatory markers and creatinine in dogs with leishmaniosis and chronic kidney disease
by: Maria Alfonsa Cavalera, et al.
Published: (2021-10-01)

Efficacy and Safety of Shenqu Xiaoshi Oral Liquid Compared With Domperidone Syrup in Children With Functional Dyspepsia
by: Yi Yu, et al.
Published: (2022-02-01)

RP-HPLC-Based Bioanalytical Approach for Simultaneous Quantitation of Cinnarizine and Domperidone in Rat Plasma
by: Mohit Vij, et al.
Published: (2023-02-01)

Domperidone loaded Caesalpinia pulcherrima galactomannan-based microspheres for nasal administration: In-vitro and In-vivo studies
by: Nilima Thombre, et al.
Published: (2022-10-01)

Corrigendum: Efficacy and Safety of Shenqu Xiaoshi Oral Liquid Compared With Domperidone Syrup in Children With Functional Dyspepsia
by: Yi Yu, et al.
Published: (2022-06-01)

Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance
by: Yisong Cheng, et al.
Published: (2021-08-01)

Optimisation of a Greener-Approach for the Synthesis of Cyclodextrin-Based Nanosponges for the Solubility Enhancement of Domperidone, a BCS Class II Drug
by: Mohit Vij, et al.
Published: (2023-04-01)

Effectiveness of Ondansetron in comparison to Domperidone for treating vomiting in acute gastroenteritis among children in a tertiary care hospital setting: A quasi-experimental study
by: Muddassir Zafar, et al.
Published: (2023-02-01)

Synthesis and Technology of Nanoemulsion-Based Pesticide Formulation
by: Isshadiba Faikah Mustafa, et al.
Published: (2020-08-01)

Women’s experiences with using domperidone as a galactagogue to increase breast milk supply: an Australian cross-sectional survey
by: Grace M. McBride, et al.
Published: (2023-02-01)

Plant extract mediated synthesis of ZnO and CeO2 nanoparticles for spectrofluorometric assay of omeprazole and domperidone in pharmaceuticals
by: Nawal A. Alarfaj, et al.
Published: (2024-02-01)

Oral nanoemulsions of candesartan cilexetil: formulation, characterization and in vitro drug release studies
by: Halah Hussein Ali, et al.
Published: (2017-06-01)

A study of in-vitro interaction of Ketotifen Fumarate with Domperidone at different gastric and intestinal pH
by: Mohammad Aktar Sayeed, et al.
Published: (2014-06-01)